PTO- 2200 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Input Field |
Entered |
SERIAL NUMBER | 90046914 |
---|---|
LAW OFFICE ASSIGNED | LAW OFFICE 109 |
PUBLISH FOR OPPOSITION DATE | 01/05/2021 |
NOTICE OF ALLOWANCE DATE | 03/02/2021 |
MARK SECTION | |
MARK | EXKIVITY |
GOODS SERVICES SECTION | |
INTERNATIONAL CLASS | 005 |
DESCRIPTION | Pharmaceutical preparations for use in oncology |
FILING BASIS | SECTION 1(b) DELETED |
SIGNATURE SECTION | |
SIGNATURE | /kmz/ |
SIGNATORY NAME | Karl M. Zielaznicki, Esq. |
SIGNATORY DATE | 06/25/2021 |
SIGNATORY POSITION | Attorney of record, New York bar member |
SIGNATORY'S PHONE NUMBER | 2127046125 |
ROLE OF AUTHORIZED SIGNATORY | Authorized U.S.-Licensed Attorney |
SIGNATURE METHOD | Signed directly within the form |
FILING INFORMATION SECTION | |
SUBMIT DATE | Fri Jun 25 15:38:42 ET 2021 |
TEAS STAMP | USPTO/DOB-XXX.XX.XX.XX-20 210625153842680437-900469 14-780a29ed98d7043b9adf8d 195f47c9a3ff38e7f302fbcab 88b3746bbdf798aff433-N/A- N/A-20210625153825586005 |
PTO- 2200 |
Approved for use through 03/31/2024. OMB 0651-0054 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |